rheumatology
Osteoarthritis

OA stem cells trial gets ethics approval

The Sydney based regenerative medicine company Regeneus has received ethics approval for its clinical trial of stem cells in patients with knee osteoarthritis. Marketed as Progenza the stem cells are produced from the adipose tissue of a healthy donor. According to a company press release the “off-the-shelf allogeneic stem cell treatment” has the potential to reduce ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic